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ABSTRACT 
Here we describe the case of a 19-year-old woman with a poorly 
differentiated ovarian Sertoli-Leydig cell tumor and an elevated serum alpha-
fetoprotein level. The patient presented with diffuse abdominal pain and 
bloating. Physical examination, ultrasound, and magnetic resonance imaging 
revealed a right ovarian tumor that was histopathologically diagnosed as a 
poorly differentiated Sertoli-Leydig cell tumor with heterologous elements. 
Her alpha-fetoprotein serum level was undetectable after tumor resection. 
Sertoli-Leydig cell tumors are rare sex cord-stromal tumors that account for 
0.5% of all ovarian neoplasms. Sertoli-Leydig cell tumors tend to be 
unilateral and occur in women under 30 years of age. Although they are the 
most common virilizing tumor of the ovary, about 60% are endocrine-
inactive tumors. Elevated serum levels of alpha-fetoprotein are rarely 
associated with Sertoli-Leydig cell tumors, with only approximately 30 such 
cases previously reported in the literature. The differential diagnosis should 
include common alpha-fetoprotein-producing ovarian entities such as germ 
cell tumors, as well as other non-germ cell tumors that have been rarely 
reported to produce this tumor marker. 
 
 
CASE REPORT 
 
 
 
 
 
A 19-year-old woman complaining of diffuse abdominal 
pain and sudden abdominal bloating was referred to our 
institute because of her family history. Her elder sister died of 
ovarian cancer at the age of 11. Her past personal medical 
history was unremarkable, except for an etonogestrel implant, 
inserted 7 months before for the prevention of pregnancy. She 
reported irregularities in her menstrual cycle since then.  
 
On physical examination, a 10-cm-sized, mobile, ovoid-
shaped, and painless pelvic mass was detected. Other physical 
assessments were negative. Routine laboratory data, cancer 
antigen 125 (CA-125), cancer antigen 19.9, carcinoembryonic 
antigen, and human chorionic gonadotropin (β-hCG) were 
within their respective normal ranges. The only altered 
laboratory finding was an increased level of alpha-fetoprotein 
(AFP) of 46.3 ng/ml (normal range < 7 ng/ml). 
 
 
 
CASE REPORT 
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Imaging findings 
Pelvic transabdominal and transvaginal ultrasounds were 
performed, and we found a complex-appearing tumor of the 
right ovary, predominantly solid with focal cystic components 
and measuring 82 × 75 × 65 mm (Fig. 1). Color Doppler 
revealed flow in the solid areas (Fig. 1C); a small amount of 
pelvic ascites was also present (Figs. 1A-C; white asterisks). 
The uterus and the left ovary were unremarkable. 
 
Since the patient was young and the ultrasound 
examination revealed a suspicious ovarian mass, magnetic 
resonance imaging was performed, and a tumor confined to the 
right ovary was seen (Figs. 1 and 2). The tumor was well 
defined and encapsulated, with the exception of a protruding 
eccentric anterior segment (Fig. 2B; white arrow). 
 
The solid component demonstrated intermediate T2 
signal, T1 signal intensity similar to muscle, and avid contrast 
uptake on fat-suppressed gadolinium-enhanced T1-weighted 
images (Figs. 2, 3A, and 3B; white-bordered arrows). The 
cystic areas had low signal on T1-weighted images, high T2 
signal, and did not enhance (Figs. 2, 3A, and 3B; white thin 
arrows). Diffusion-weighted images (b1000 s/mm2) showed 
high-signal intensity in the solid components of the tumor, and 
apparent diffusion coefficient images showed low-signal 
intensity of these components; therefore, restricted diffusion 
was present (Figs. 3C-D; white-bordered arrows). A small 
amount of ascites was detected only in the pelvis (Figs. 2A-C; 
black asterisks). No inguinal, pelvic, and para-aortic 
lymphadenopathies, nor peritoneal implants or hepatic 
metastases, were detected.  
 
Management and follow-up 
Because the tumor had magnetic resonance imaging 
features suggestive of malignancy, and seemed resectable, 
fertility-sparing salpingo-oophorectomy, partial omentectomy, 
and peritoneal biopsies were performed. The pelvic and 
abdominal cavities were explored during surgery, and neither 
peritoneal implants nor lymphadenopathies were found.  
 
The right ovary, weighing 140 g and with the longest axis 
measuring 8 cm, exhibited an area of rupture on the surface 
associated with tumor extravasation (Fig. 4A), as described on 
gross examination of the pathologic specimen. The ovarian 
mass was a tan-grayish variegated tumor, predominantly solid 
with small cystic areas (Fig. 4B). The histopathologic 
examination revealed a tumor composed of 2 cell populations: 
Sertoli cells and Leydig cells. Leydig cells were seen isolated, 
or in small aggregates, admixed in between Sertoli cell 
aggregates. Sertoli cells were arranged in various patterns, 
forming hollow tubules and cords in an edematous stroma 
(Fig. 5A). There were areas of marked edema producing a 
microcystic pattern (Fig. 5B), and in very few areas, the Sertoli 
cells were arranged to form slit-like spaces giving a retiform 
appearance (Fig. 5C). Poorly differentiated areas of immature 
Sertoli cells growing in a predominantly diffuse pattern with 
small tubular differentiation and a high mitotic index (with an 
average of 26 mitoses in 10 high power fields) were identified 
(Fig. 5D). A small focus of heterologous elements was found, 
with mature intestinal differentiation (Fig. 5E). Due to the 
reduced dimension of this focus, with the longest axis 
measuring 0.9 mm, the immunohistochemichal study with AFP 
was inconclusive regarding this small focus of heterologous 
components, and no expression was found in the Sertoli cells 
or in the Leydig cell components. There were foci of necrosis. 
No lymphovascular invasion was documented. The multiple 
peritoneal tissue biopsies received were negative for tumor 
cells. 
 
The diagnosis of poorly differentiated Sertoli-Leydig cell 
tumor (SLCT) with heterologous gastrointestinal epithelium 
was made. 
 
The serum AFP level was undetectable after tumor 
resection. 
 
Adjuvant chemotherapy treatment options were discussed 
in the multi-disciplinary gynecology oncology group, and the 
patient was considered for a bleomycin, etoposide, and 
cisplatin (BEP) regimen. Thus far, the patient has undergone 4 
months of therapy without major complications. 
 
 
 
 
We report a rare case of a poorly differentiated ovarian 
SLCT with foci of heterologous gastrointestinal epithelium 
that presented with a slight elevation of serum AFP levels. 
Since the early 1980s, only approximately 30 cases of SLCTs 
associated with elevated levels of AFP have been reported in 
the literature [1-24]. 
 
AFP in ovarian tumors - differential diagnosis 
AFP is a major plasma glycoprotein produced by the liver, 
yolk sac cells, and fetal gastrointestinal tract [1,4,5]. It can 
also be produced by Sertoli cells, Leydig cells, and 
heterologous components, such as hepatocytes and/or 
gastrointestinal epithelium [1,4]. 
 
Commonly, elevated serum levels of AFP have been 
detected in hepatocellular carcinoma and ovarian germ cell 
tumors, such as yolk sac tumor (endodermal sinus tumor) and 
embryonal carcinoma, among others [25]. Therefore, the 
presence of a probably malignant unilateral ovarian mass in a 
young woman, in whom the only abnormal laboratory finding 
was the presence of elevated serum levels of AFP, led to the 
suspicion of a yolk sac tumor. The presence of a yolk sac 
tumor was the first diagnosis considered, since it is strongly 
associated with the production of AFP and is the second most 
frequent type of malignant germ cell tumor (after 
dysgerminoma), often occurring mixed with other entities [26]. 
Moreover, as in the case we present, it occurs mainly in the 
second and third decades of life as a unilateral, mainly solid 
tumor frequently associated with cystic areas. However, this 
type of germ cell tumor frequently exhibits intra-abdominal 
spread, invasion of the surrounding structures, and lymphatic 
metastases, none of which were present [26]. Although AFP 
serum levels are frequently elevated in embryonal carcinoma 
without admixed yolk sac component, this rare type of tumor 
generally presents as an aggressive large solid mass frequently 
associated with elevated β-hCG serum levels [27]. 
 
DISCUSSION 
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Another germ cell tumor that should be included in the 
differential diagnosis is immature teratomas [28]. The finding 
of an elevated level of serum AFP has been reported in 33-
65% of patients with immature teratomas [29,30]. Although 
the lack of demonstrable fat and calcifications with ultrasound 
and magnetic resonance imaging makes this diagnosis 
improbable, it should not be ruled out in a young woman with 
a unilateral heterogeneous mass, since scanty fatty tissue may 
not be identified on imaging studies. 
 
On rare occasions, non-germ cell tumors of the ovary have 
been described to produce AFP [25]. These include 
histological types of epithelial tumor, sex cord stromal tumors, 
and metastatic tumors to the ovary [25]. 
 
The diagnoses of an ovarian epithelial tumor and ovarian 
metastasis were very unlikely in this clinical setting, since they 
occur mainly in older age groups. There have been sparse 
cases reported of AFP-producing epithelial tumors. These 
include hepatoid carcinoma, ovarian serous carcinoma, ovarian 
clear cell carcinoma, ovarian endometrioid carcinoma, ovarian 
undifferentiated carcinoma, ovarian mucinous carcinoma, and 
ovarian malignant mixed Müllerian tumor [25, 31-42].  
 
Based on the literature reviewed, to our knowledge, the 
only case of an AFP-producing epithelial tumor occurring in 
the first 2 decades of life was a clear cell carcinoma that 
simulated a yolk sac tumor in a 17-year-old patient, reported 
by Bahri et al. [36]. Ovarian metastases producing AFP have 
been primarily described in older women with gastric or 
hepatocellular carcinoma [43,44]. The histological types of sex 
cord stromal tumors that have been reported to be associated 
with raised serum AFP are granulosa cell tumors and SLCTs. 
Although only sporadic cases of juvenile granulosa cell tumors 
associated with high serum AFP have been described in the 
literature, this was a diagnosis that could not be ruled out 
clinically [25,45]. Similar to this case, juvenile granulosa cell 
tumors generally occur in women aged less than 30 years of 
age and almost always present as a unilateral, solid ovarian 
mass with variable cystic/hemorrhagic components.  
 
Despite the few reports of ovarian SLCTs associated with 
raised levels of AFP, they are the most common AFP-
producing non-germ cell tumor of the ovary [25]. 
 
Etiology and demographics 
SLCTs are more likely to occur in young women, as in our 
case, with approximately 75% of cases occurring in women 30 
years of age or younger [46,47]. However, a few cases have 
been reported in postmenopausal women [48,49]. SLCTs are 
unilateral in more than 98% of cases, and 80% are confined to 
the ovary at the time of diagnosis [27,46]. They contain 
variable portions of Sertoli cells and Leydig cells, and 
according to the degree of differentiation of these cells, SLCTs 
are further divided into 4 histologic subtypes: well 
differentiated, intermediately differentiated, poorly 
differentiated, and retiform variant [46]. These last 3 
categories may have variants that contain heterologous 
elements [46]. Heterologous elements are reported to be 
present in 20% of SLCTs and are represented by endodermal 
and mesenchymal elements [50]. Heterologous elements of the 
endodermal type may be hepatocyte cells or gastrointestinal 
mucin-secreting elements, whilst heterologous mesenchymal 
elements may be in the form of cartilage and skeletal muscle. 
Most previous reports have demonstrated AFP expression by 
immunohistochemistry in Sertoli cells only, in Leydig cells 
only, in both Sertoli and Leydig cells, in hepatoid cells, and in 
heterologous gastrointestinal epithelium [1-25]. 
 
In our case, the specific type of AFP-producing cell could 
not be found. 
 
Clinical and imaging findings 
About 30-50% of SLCTs produce androgens (testosterone 
and a variety of androgenic precursors), which are responsible 
for androgen excess signs, such as oligomenorrhea, 
amenorrhea, and virilizing symptoms [27,47].Many are non-
functioning, and a small subset of tumors are estrogenic 
[27,47,51]. 
 
Here, we present an unusual case in which the only altered 
laboratory finding was a slightly elevated serum level of AFP 
(46.3 ng/m; normal range < 7 ng/ml). Both androgen hormones 
and tumor markers (CA-125; carcinoembryonic antigen; β-
hCG) were in the normal range. The patient presented with 
sudden abdominal pain and swelling, which are unspecific 
signs but very common complaints of hormonally inactive 
tumors.  
 
There are no SLCT-specific imaging features. 
  
Ultrasound remains the primary imaging modality for the 
assessment of adnexal masses [52]. Since transabdominal 
ultrasound is useful in the identification and characterization 
of large masses and those positioned superiorly and laterally in 
the pelvis, and transvaginal ultrasound provides excellent 
visualization of adnexal masses, both approaches were 
performed [52]. Ultrasound reflects the gross pathologic 
characteristics of the tumor and usually reveals a well-defined 
hypoechoic mass or a predominantly solid heterogeneous mass 
with multiple cystic areas, as in the case presented here. Color 
Doppler imaging may help detect virilizing SLCTs that may be 
small and difficult to visualize using transvaginal ultrasound 
[47,53,54]. 
 
Computed tomography imaging usually reveals a soft 
tissue density adnexal mass with heterogeneous or 
homogenous avid contrast enhancement by the solid 
components of the tumor [29]. Calcification is uncommon 
[29,47]. 
 
With magnetic resonance imaging, the solid components 
of the tumor display different signal intensity on T2-weighted 
imaging, depending on the amount of fibrous stroma. 
However, a strong low-signal intensity on T2-weighted images 
is not commonly encountered [46,47,55,56].  Cystic portions 
usually display with high signal on T2-weighted images and 
with low signal on T1-weighted images, but sometimes hardly 
noticeable high-signal intensity on T1-weighted images can be 
seen [57]. Solid components tend to show avid homogenous or 
heterogeneous contrast uptake on gadolinium-enhanced 
images, whereas cystic areas are non-enhancing [29]. 
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Treatment and prognosis  
Due to the lack of standardized protocol guidelines, there 
is no uniform therapeutic approach to these tumors [58]. The 
type of surgical approach depends on patient age and 
preference, tumor stage, and tumor differentiation. Most of 
these tumors are unilateral and confined to the ovary at the 
time of clinical diagnosis. Hence, in patients at reproductive 
age, with stage Ia/Ib disease, who prefer fertility preservation, 
unilateral salpingo-oophorectomy with or without the 
exploration of the contralateral ovary is appropriate [59]. 
 
In women with intermediate or poorly differentiated stage 
Ic disease, unilateral salpingo-oophorectomy with formal 
staging surgery is a pertinent treatment [59]. The patient in this 
report was involved in the decision-making process and 
expressed her wish to preserve fertility. She had Ic stage 
disease (rupture of the capsule), so unilateral salpingo-
oophorectomy plus standard staging surgery (partial 
omentectomy and several peritoneal biopsies) were performed. 
According to Brow et al. and Thrall et al., lymphadenectomy 
may be omitted from the surgery staging procedure of sex 
cord-stromal tumors due to the rarity of lymph node metastases 
in these types of tumors [60,61]. 
 
Women who do not wish to preserve their fertility or with 
advanced stage disease (stage II or higher) should be 
considered for radical surgery with total abdominal 
hysterectomy and bilateral salpingo-oophorectomy or 
cytoreductive surgery [59]. 
 
Management of SLCTs after surgery is not clearly defined 
and is based on limited studies [58,59]. 
 
Adjuvant chemotherapy is recommended for patients with 
advanced disease, intermediate and poor tumor differentiation, 
retiform pattern, and presence of heterologous elements [59]. 
A retrospective study of 21 patients treated in 11 centers 
conducted by Sigismondi et al. concluded that the prognosis of 
patients with well differentiated SLCT is excellent without 
adjuvant chemotherapy. In contrast, patients with advanced 
stage or with intermediate or poorly differentiated tumors 
appear to benefit from adjuvant chemotherapy [51]. In this 
case, the patient underwent adjuvant chemotherapy with the 
BEP regimen (bleomycin, etoposide, and cisplatin) because of 
poor tumor differentiation and the presence of heterologous 
elements. BEP is an effective first-line chemotherapeutic 
regimen [58,59]. However, toxicities and lack of durable 
activity associated with BEP may limit its use [59,62]. A 
retrospective review of 44 patients with sex cord-stromal 
tumors concluded that taxanes may be an effective treatment, 
and combination therapy with taxanes and platinum warranted 
further investigation [62]. Currently, a randomized phase II 
trial conducted by the Gynecologic Oncology Group of the 
United Cancer Institute is comparing the effectiveness of 
paclitaxel and carboplatin versus BEP in the treatment of 
advanced and recurrent sex cord-stromal tumors. 
 
SLCTs are typically associated with a good prognosis. 
 
Disease behavior correlates with the stage and with the 
degree of differentiation at the time of diagnosis [47,56,63]. 
Young and Scully reviewed 207 cases of SLCTs, and clinical 
malignancy was identified in 18%. All well-differentiated 
tumors were benign; however, 11% of the intermediately 
differentiated tumors, 59% of poorly differentiated tumors, and 
19% of tumors with heterologous elements were malignant 
[63]. Sigismondi et al. reported 5-year survival rates of 100% 
for patients with well-differentiated tumors and 77.8% for 
those with intermediate and poorly differentiated tumors. 
Patients with stage I SLCTs had a 5-year overall survival rate 
of 92.3%, whereas that for patients with stage > I disease was 
33.3% [51]. 
 
In contrast to other sex cord-stromal tumors, such as 
granulosa cell tumors, which may have late recurrence of the 
disease, malignant SLCTs tend to recur 2 to 3 years after the 
initial diagnosis [58, 64]. Recurrence is usually confined to the 
pelvis and abdomen, and typically presents without distant 
metastases. Without exception, when reviewing the cases 
reported in the literature of AFP-producing SLCTs, including 
the case we present here, serum AFP fell to undetectable levels 
postoperatively. There are few reports of AFP-producing 
SLCT recurrences, and to our knowledge, all cases had raised 
AFP levels at the onset of the ovarian mass [3,22]. 
Nonetheless, there is limited information on surveillance 
strategies and the prognosis of patients with AFP-producing 
SLCTs. 
 
National Comprehensive Cancer Network surveillance 
guidelines for sex cord-stromal tumors recommend physical 
examination, review of symptoms, and measurement of tumor 
markers if they were initially elevated every 2-4 months during 
the first 2 years and every 6 months thereafter [65]. There are 
insufficient data to support the periodic use of radiographic 
imaging. Computed tomography imaging and measurement of 
tumor markers are recommended when there is suspicion of 
recurrence [65]. 
 
 
 
 
Although rare, AFP-producing non-germ cell tumors must be 
considered in the presence of an ovarian mass associated with 
an elevated serum AFP level. In a young woman, the 2 major 
diagnoses that need to be taken into account are SLCTs and 
juvenile granulosa tumors, which must be distinguished 
clinically, radiologically, and pathologically from AFP-
producing germ cell tumors, such as yolk sac tumors, 
immature teratomas, and embryonic carcinomas, as the 
diagnosis affects the treatment plan for the patient. 
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Figure 1: A 19-year-old female patient with a poorly differentiated Sertoli-Leydig cell tumor of the right ovary with 
heterologous gastrointestinal epithelium. Pelvic transvaginal ultrasound with a 10-MHz endocavitary probe. A heterogeneous 
complex-appearing mass, predominantly solid with focal cystic areas was detected in the right ovary (1A and 1B). The tumor 
exhibited abundant and low resistance flow within the solid areas on color Doppler imaging (1C). These sonographic 
characteristics, combined with a small amount of pelvic ascites (white asterisks; 1A, 1B, and 1C), suggested a malignant 
nature. 
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Figure 2: A 19-year-old female patient with a poorly differentiated Sertoli-Leydig cell tumor of the right ovary with 
heterologous gastrointestinal epithelium.  
 
Pelvic magnetic resonance imaging.  
Axial T2-weighted images (2A and 2B), sagittal T2-weighted image (2C, and axial T1-weighted image (2D) showed a 
heterogeneous, well defined tumor of the right ovary. The tumor was well encapsulated, with the exception of a protruding 
eccentric anterior segment (white arrow; 2B). Solid components showed intermediate T2 signal (white-bordered arrows; 2A-C) 
and T1 signal intensity similar to muscle (white-bordered arrow; 2C), while other components had high T2 signal (thin arrows; 
2A-C) and low-signal on T1-weighted images (thin arrow; 2D), suggesting a cystic nature. A small amount of ascites was 
identified in the pelvic recesses (black asterisks; 2A-C).  
 
(Philips Intera Pulsar 1.5T: T1-weighted images [TR = 604; TE = 10]; T2-weighted images [TR = 3500; TE = 100]). 
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Figure 3: A 19-year-old female patient with a poorly differentiated Sertoli-Leydig cell tumor of the right ovary with 
heterologous gastrointestinal epithelium.  
 
Pelvic magnetic resonance imaging.  
Axial gadolinium-enhanced fat-suppressed T1-weighted images showed avid contrast uptake by the solid components of the 
tumor (white-bordered arrows; 3A and 3B), without enhancement of the cystic components (thin arrows; 3A and 3B).  
Axial diffusion-weighted image (b1000s/mm2) showed high-signal intensity of the solid components of the tumor (white-
bordered arrow; 3C), while the apparent diffusion coefficient map showed low-signal intensity of the same components (white-
bordered arrow; 3D). These findings were consistent with restricted diffusion.  
 
(Philips Intera Pulsar 1.5T: dynamic contrasted-enhanced image obtained with a 3-dimensional gradient-recalled echo T1-
weighted sequence after the administration of 0.1 mmol/kg of gadopentetate dimeglumine at a rate of 2 mL/sec acquired 2 
minutes after injection; axial diffusion-weighted image [TR = 2882; TR = 67; flip angle 90º performed with b values of 1000 
s/mm2]). 
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Figure 4: A 19-year-old female patient with a poorly differentiated Sertoli-Leydig cell tumor of the right ovary with 
heterologous gastrointestinal epithelium. Macroscopic examination revealed an enlarged ovary (140 g and 8 cm in length at the 
longest axis) with a smooth gray-whitish surface with rupture and tumor extravasation (4A). On cut sections, the ovary was 
replaced by a variegated solid and multicystic tumor (4B). 
 
 
Figure 5: A 19-year-old female patient with a poorly differentiated Sertoli-Leydig cell tumor of the right ovary with 
heterologous gastrointestinal epithelium. Microscopic examination of hematoxylin- and eosin-stained sections (200×). The 
tumor was composed of Sertoli cells arranged in hollow tubules and inter-anastomosing cords in an edematous stroma (5A), 
and in some areas, marked edema produced a microcystic pattern of the Sertoli cell component, intermingled with Leydig cells 
(5B). In addition, areas of slit-like spaces of the Sertoli cell component were observed in a background of hyalinized stroma 
(5C). There were also poorly differentiated areas composed of immature Sertoli cells growing in a predominantly diffuse 
pattern with small tubular differentiation and a high mitotic index (5D). A small focus (0.9 mm) of heterologous elements was 
found, composed entirely of mature intestinal gland (5E). 
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 Ultrasound Computed Tomography Magnetic Resonance Imaging 
Sertoli-Leydig 
cell tumor 
 Unilateral well-defined 
hypoechoic and 
heterogeneous mass 
predominantly solid with 
multiple cystic areas  
 Abundant flow within the 
solid areas on color 
Doppler imaging  
 Ascites may be present 
 Well defined unilateral soft 
tissue density mass with avid 
contrast enhancement by the 
solid components of the tumor 
 Ascites may be present 
 Presence of enlarged lymph 
nodes - rare 
 Solid components -T1 signal intensity 
similar to muscle; intermediate/low T2 
signal depending on the amount of 
fibrous stroma; avid contrast uptake 
 Cystic areas - high T2 signal; low-signal 
on T1-weighted images 
 Ascites may be present 
 Presence of enlarged lymph nodes - rare 
Yolk sac tumor  Unilateral mainly solid 
large mass with cystic 
areas 
 Ascites may be seen 
 Unilateral large complex mass  
 Strong enhancement of the solid 
areas 
 Sometimes central necrosis and 
hemorrhage are present 
 Enlarged lymph nodes, ascites, 
peritoneal implants, and 
invasion of the adjacent 
structures may be present 
 Solid component –hypo-intense signal on 
T1-weighted images; heterogeneous high 
T2 signal; avid contrast uptake. 
 Foci of hemorrhage – high T1 signal 
 Necrosis – high T2 signal 
 Enlarged lymph nodes, ascites, 
peritoneal implants, and invasion of the 
adjacent structures may be present 
Embryonal 
carcinoma 
 Unilateral, very large, 
predominantly solid mass 
with extensive anechoic 
areas reflecting necrosis 
 Ascites may be present 
 Unilateral, very large, 
predominantly solid mass with 
large low- attenuation areas 
reflecting necrosis and/or with 
high attenuation areas reflecting 
hemorrhage 
 Avid contrast uptake by the 
solid portions of the tumor 
 Ascites, retroperitoneal 
lymphadenopathies, and 
peritoneal implants may be seen 
 Predominantly low T1 signal mass  that 
may display areas of high-signal intensity 
due to the presence of hemorrhage 
 Predominantly high  T2 signal intensity 
mass due to the presence of necrosis 
 Avid contrast uptake by the solid 
portions of the tumor 
 Ascites, retroperitoneal 
lymphadenopathies, and peritoneal 
implants may be seen 
Immature 
teratoma 
 Heterogeneous 
predominantly solid 
adnexal large mass with 
cystic components  
 Foci of fat - echogenic 
foci 
 Calcifications may be 
present - highly echogenic 
foci with posterior 
acoustic shadowing  
 Large heterogeneous mass with 
enhancing solid areas and cystic 
components 
 Presence of fat – foci of low-
attenuation 
 Calcifications- foci of high-
attenuation 
 Large heterogeneous mass with 
enhancing solid areas and with cystic 
components 
 Presence of fat – high T1 and T2 signal 
intensity; signal loss on fat sat sequences 
Juvenile 
granulosa cell 
tumor 
 Unilateral, multicystic 
large mass with solid 
components 
 Irregular thin or thick 
septations 
 If cystic hemorrhage – 
heterogeneous 
echogenicity within the 
cysts 
 Unilateral multicystic large 
mass with enhancing solid 
components and septations 
 Solid components - intermediate T2 
signal; contrast uptake 
 Thick septations – low signal on T2-
weighted images 
 Cystic areas - high T1 signal due to 
hemorrhage; fluid-fluid levels 
 
Table 1: Differential diagnosis table of ovarian tumors associated with an elevated serum level of alpha-fetoprotein in a young 
woman. 
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Etiology Type of sex cord-stromal tumor of the ovary 
Proliferation of variable proportions of Sertoli cells, Leydig cells, and fibroblasts 
Incidence 0.5% of all ovarian neoplasms 
Gender ratio Women 
Age predilection 75% of cases under 30 years of age 
Risk factors Unknown 
Treatment  Unilateral salpingo-oophorectomy  (Stage I; women in reproductive age) 
 Total abdominal hysterectomy and bilateral salpingo-oophorectomy (≥ Stage II) 
 Adjuvant chemotherapy (≥ Stage II; presence of poorly differentiated and heterologous elements) 
 Adjuvant chemotherapy + radiotherapy – unknown 
Prognosis  Most of these tumors behave in a benign fashion 
 Malignant behavior in 10–30% of cases 
Findings on 
imaging 
 Ultrasound – Well-defined hypoechoic and heterogeneous mass, predominantly solid with multiple 
cystic areas and abundant flow within the solid areas on color Doppler imaging  
 Computed tomography - Soft tissue density mass with avid contrast enhancement  
 Magnetic resonance imaging - Solid components show intermediate T2 signal and T1 signal intensity 
similar to muscle; fibrous stroma show low T2 signal; cystic areas have high T2 signal and low signal 
on T1-weighted images; gadolinium-enhanced images show avid contrast uptake by the solid 
components of the tumor 
 Histopathologic findings - Definitive diagnosis 
 
Table 2: Summary table of Sertoli-Leydig cell tumor characteristics 
 
 
 
 
 
 
 
 
 
 
AFP - Alpha-fetoprotein 
BEP - Bleomycin, etoposide, and cisplatin regimen 
β-hCG - Human chorionic gonadotropin  
CA-125 - Cancer antigen 125 
SLCT- Sertoli-Leydig cell tumor 
 
 
 
 
 
Sertoli-Leydig tumor; Alpha-fetoprotein; Sex cord-stromal 
tumor; Ovarian tumor; Ultrasound; Magnetic resonance 
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